Learn how tissue engineering and immune‑evasive iPSC technology were combined to produce vascularized liver organoids for potential off‑the‑shelf therapies.
Key Takeaways
- Please note there may be errors present which affect the content, and all legal disclaimers apply
- Induced pluripotent stem cell (iPSC)-derived cells represent a promising alternative
- Lineage identity was validated by gene and protein expression analysis